The present study describes the separation and purification of a reverse transcriptase and cellular DNA polymerases from the human spleen of a patient with myelofibrotic syndrome. The specific requirements with respect to bivalent cations and template-primers for DNA polymerase-a, DNA polymerase-,B and DNA polymerase-y, as well as for the reverse transcriptase, are reported. Sedimentation-velocity measurements of the purified enzymes gave values of 150000,40000, 100000 and 70000 daltons for DNA polymerase-a, DNA polymerase-/J, DNA polymerase-y and the reverse transcriptase respectively. Serological studies have shown that the reverse transcriptase from human spleen is not antigenically related to cellular DNA polymerase-ca, -fl or -y, but is antigenically related to reverse transcriptase from simian sarcoma virus and gibbon-ape leukaemia virus.
Much attention has been centred on the involvement of RNA tumour viruses in human cancer. Direct investigation of human tumour cells or leukaemic plasma by the electron microscopy has not proved very useful. Particles resembling animal C-type RNA tumour viruses have been described (Dmochowski et al., 1965; Gross, 1970) , but the possibility that these observations are artifacts cannot be disputed since the tumours were not assayed for biological activity.
Since the initial discovery of an oncornaviral-like reverse transcriptase activity in human leukaemic cells by Gallo et al. (1970) , many studies have been carried out to detect this enzymic activity in a variety of malignant tissues and virus-infected cells (for review see Gallo, 1974) . The object of these studies has been to obtain evidence for the presence ofan RNA tumour virus in certain neoplasmic cells of man to determine if this enzyme can be useful as a marker for the detection of viral information in human malignant diseases and to study the relationship between cellular DNA polymerases and the viral reverse transcriptase. In many of these studies, strict criteria for the characterization of reverse transcriptase were not applied, since the enzyme was not purified to homogeneity. So far, only two reports are available Witkin et al., 1975) where human reverse transcriptase has been purified to homogeneity. The characterization of template specificity or ionic requirements do not necessarily constitute proof of the presence of a reverse transcriptase activity. One of the cellular DNA polymerases, DNA poly-* Dedicated to Professor Erich Heinz on his 65th birthday.
Vol. 167 merase-y, resembles, in several of its biochemical properties, the viral reverse transcriptase, and was confused by several investigators with this enzyme. Thus the designation of an enzyme as reverse transcriptase requires not only its biochemical characterization, but also its serological analysis.
Myelofibrotic syndrome has been reported to result from a variety ofaetiological factors (see review by Hunstein & Hauswald, 1974) . Pathological investigations indicate that the syndrome differs from leukaemia (Leonard et al., 1957; Gilbert, 1970; Ward & Block, 1971) , generally occurring in the middleaged or elderly (Pitcock et al., 1962; Silverstein et al., 1967 ) although a few cases in children have been reported (Rosenberg & Taylor, 1958) .
The first indication for a virus aetiology of myelofibrotic syndrome came from data reported by our laboratory (Chandra et al., 1975) . A DNA polymerase resembling the reverse transcriptases of RNA tumour viruses was isolated from a post-operative spleen specimen of a girl of 21 years having myelofibrotic syndrome. The present paper describes the isolation and biochemical characterization of the cellular DNA polymerases and reverse transcriptase from this spleen specimen. The serological specificities of these enzymes and the immunological relatedness of our reverse transcriptase to those from other primate oncornaviruses are presented.
Experimental

Materials
Labelled deoxynucleoside triphosphates were from NEN-Chemicals G.m.b.H., Dreieichenhain, Germany; non-labelled deoxynucleoside triphos-R phates were from Calbiochem A.-G., Lucerne, Switzerland, or Boehringer, Mannheim, Tutzing, Germany. Anti-(reverse transcriptase) IgG* from gibbon-ape leukaemia virus, simian (woolly monkey) sarcoma virus, Rauscher leukaemia virus and avian myeloblastosis virus, and reverse transcriptases of gibbon-ape leukaemia virus and simian sarcoma virus were from Litton Bionetics, Bethesda, MD, U.S.A. The reverse transcriptase of avian myeloblastosis virus was from Schwarz/Mann, New York, NY, U.S.A. 'Activated' DNA (salmon sperm) was prepared by the method of Schlabach et al. (1971) . DEAE-cellulose (DE23) and phosphocellulose P were from Serva, Heidelberg, West Germany. DEAE-cellulose (DE52; microgranular) was obtained from Whatman Biochemicals, Maidstone, Kent, U.K. DNA-cellulose was prepared from cellulose powder (2200ff; Machery, Nagel and Co., Duren, Germany) by the methods of Alberts & Herrick (1971 (chain length 12-18) .
slowly for 1 h at4°C. The homogenatewascentrifuged at 17000g for 15min, the supernatant saved and the pellet re-extracted as before bycombiningwith 50ml of the same buffer, hand homogenization and slow stirring for 1 h. The re-extracted pellet was centrifuged at 17000g for 15min; the pellet (particulate debris) was discarded and the supernatant combined with the previous 17000g supernatant. The combined 17000g supernatants, containing solubilized microsomal extracts, were centrifuged at 171000g for 1 h. The resulting supernatant was decanted and saved; the pellet was re-extracted with 50ml of the same buffer, hand-homogenized, and centrifuged at 171 OOOg for 1 h. Phosphocellulose chromatography Phosphocellulose (P) was prepared by the method of Burgess (1969) , equilibrated with buffer C and then treated with bovine serum albumin according to the method of Sedwick et al. (I 972a) . The phosphocellulose was then washed with buffer C containing 0.05M-KCl until no more bovine serum albumin was eluted (A280 of the effluent). Two columns (diam., 1.6cm; vol., 20ml of wet-packed phosphocellulose) were prepared. The concentrated and dialysed 0.05M-KCI washing from the DE52-cellulose column was applied to one column. After adsorption, the column was washed with 20ml of buffer C containing 0.07M-KCI, and eluted with a 200ml linear gradient with respect to concentration (0.1-0.7M-KCI) in buffer C. Then 100 2ml fractions were collected and every second tube was assayed for DNA polymerase activity.
The concentrated and dialysed 0.3 M-KCI washings from the DEAE-cellulose (DE52) column was adsorbed on the second phosphocellulose column, washed with 20ml of buffer C containing 0.07M-KCI and eluted with a 200ml linear gradient of 0.1-0.5M-KCl in buffer C. Then 100 2ml fractions were collected and every second tube was assayed for DNA polymerase activity. Peak activities were pooled and concentrated by dialysis against poly(ethylene glycol) buffer, then dialysed against buffer D [0.05 M-Tris/HCl (pH7.5)/1 mM-dithiothreitol/0.05 MKCl/20 % (v/v) glycerol containing 0.0mg of bovine serum albumin/ml of buffer].
DNA-cellulose chromatography DNA-cellulose was prepared from powdered cellulose by the procedure of Alberts & Herrick (1971) , and stored in 0.01 M-Tris (pH 7.4)/I mM-EDTA containing 0.15 M-NaCl at -20°C. The prepared DNAcellulose was poured into a column (diam., 1.0cm) and allowed to settle at room temperature (25°C) with deaeration (vol., 5ml of wet-packed cellulose). The column was then placed in a cold-room (4°C) and equilibrated with buffer D until the effluent had the same pH and conductivity as the buffer.
A sample (5 ml) of the concentrated and dialysed peaks from the second phosphocellulose column was equilibrated with buffer D by the addition of 7.5 ml of buffer D containing an additional 0.067mg of bovine serum albumin/ml of buffer. The sample was slowly adsorbed on the DNA-cellulose column (2ml/h). After adsorption, the column was washed with 5 ml of buffer D and eluted with a 50ml linear gradient of 0.075-0.4M-KCI in buffer D. Then 100 0.5 ml fractions were collected and every second tube was assayed for DNA polymerase activity. DNA . Reaction mixtures were incubated for 60min at 37°C (MgCI2 present) or 30°C (MnCI2 present) and stopped by the addition of 0.36mg of bovine serum albumin and 3ml of cold 10 % (w/v) trichloroacetic acid. Acid-precipitable material was collected on Whatman glass-fibre paper discs, washed three times with 5 ml of 5 % (w/v) trichloroacetic acid, dried at 100°C for 30min, then suspended in lOml of toluene scintillator fluid (Quickszint; Zinsser, Frankfurt, Germany) and counted for radioactivity in a liquid-scintillation spectrometer.
Molecular-weight determination Molecular-weight determination of the spleen reverse transcriptase was performed by glycerolgradient centrifugation by using a modification of the procedure of Martin & Ames (1961) . Protein concentrations were measured by the method of Lowry et al. (1951) with bovine serum albumin as standard. The enzyme was dialysed against buffer F [0.05M-Tris/HCl (pH 7.5)/i mM-dithiothreitol/I mM-EDTA/ 0.20M-NaCl] and 1 ml of the dialysis residue (140,ug) was layered on a pre-formed 5-20% (v/v) glycerol gradient (9ml, in buffer F). Three external protein standards, ovalbumin (mol.wt. 45000), bovine serum albumin (mol.wt. 67000) and aldolase (mol.wt. 147000), were prepared at concentrations of 1 mg/ml of buffer F and similarly layered on parallel gradients. Gradients were centrifuged at 4°C for 24h at 200000g, then fractionated in 0.3 ml portions from the topbyusinganISCO density-gradient fractionator and the A280 of each protein standard sample was determined. DNA polymerase activity of the fractionated reverse transcriptase samples (0.3ml) was assayed by the standard DNA polymerase assay system. A portion (0.04ml) of each sample was assayed with poly(rC) * oligo(dG) as template-primer, in the presence of 1 mM-MnCl2, 0.06 M-KCI and other reaction substrates, as described above, in a final incubation volume of 0.25 ml (pH 7.5). Mixtures were incubated for 1 h at 30°C and processed by the methods described above for assay systems.
As a further measure of the molecular weight of the spleen reverse transcriptase, the isolated enzyme and the same protein standards were subjected to polymerase-| polymerase-y Scheme 1. Methods used to separate and isolate the DNA polymerases from myelofibrotic spleen [adaptedfrom Lewis et al. (1974a,b)] disc gel electrophoresis by the procedures of Davis (1964) and Ornstein (1964) . Molecular weights of DNA polymerase-a, -fl and -y were determined by sucrose-gradient centrifugation by a modification of the procedure of Martin & Ames (1961 Fraction no. (Fig. 2) . DNA polymerase assay of samples indicated that DNA polymerase-a and -y were eluted at a concentration of0.27-0.40M-KCI. The peaks were pooled and further chromatographed on DNA-cellulose. DNA polymerase assay of samples from the DNAcellulose column is shown in Fig. 3 . Resolution of the two enzymes was achieved: DNA polymerase-ax was eluted at a concentration of 0.13 M-KCI and DNA polymerase-y was eluted at 0.19M-KCI.
Molecular-weight determination
Results of the glycerol-gradient centrifugation of the purified spleen reverse transcriptase and three protein standard markers are shown in Fig. 4 . The apparent molecular weight of the enzyme, assuming a globular shape, is approx. 70000. Disc gel electrophoreses of the enzyme demonstrated a mobility corresponding to that of bovine serum albumin, further verifying the glycerol-gradient value of 70000 daltons for the molecule. This determination agrees with the reported molecular weight of reverse transcriptases isolated from other mammalian type-C viruses (Grandgenett et al., 1972; Tronick et al., 1972; Abrell & Gallo, 1973; Gallo et al., 1975; Mondal et al., 1975; Witkin et al., 1975) . However, in contrast with the reverse transcriptase ofleukaemic cells, where two size classes of 70000 and 130000 daltons have been reported , only one molecular species of 70000 daltons could be detected in the human myelofibrotic spleen.
Molecular-weight determination of the cellular DNA polymerases is shown in Fig. 5 . The sucrosegradient centrifugation of DNA polymerase-,B indicates a mol.wt. of approx. 40000. Other laboratories (Smith & Gallo, 1972; Sedwick et al., 1972a; Chang, 1973; Lewis et al., 1974a) Sedwick et al. (1972a) , Smith & Gallo (1972) , Lewis et al. (1974b) and Loeb (1974 (Sedwick etal., 1972a; Loeb, 1974; Lewis et al., 1974a) . DNA polymerase-x was also sensitive to high ionic strength and pH. The enzyme functioned best at pH 7.5 and at 60mM-KCI. This agrees with the findings of Bollum (1960) , who found DNA polymerase-a to function optimally at pH7.0-7.5 and at low ionic strength.
DNA polymerase-fl preferentially transcribed poly(dA) *(dT)jo, but transcribed poly(rA) poorly and poly(rC) oligo(dG) not at all. Smith & Gallo (1972) and Lewis et al. (1974a) have found similar results for this enzyme isolated from human lymphocyte cells. DNA polymerase-f, showed a preference for higher ionic strength and pH, which agrees with Table 1 . Bivalent cation and template specificities of the cellular DNA polymerases and reverse transcriptase isolated from human myelofibrotic spleen Reactions were performed as described for the DNA polymerase assay system. Reactions containing the reverse transcriptase enzyme were carried out at pH7.5, with DNA polymerase-a at pH 7.5 and DNA polymerase-,8 and -y at pH7.8. All reactions with DNA polymerase-oc and those with the template-primer 'activated' DNA contained 0.06M-KCI; all others contained 0.125M-KCI.
[ Sedwick et al. (1972b) .
The template-primer specificities of DNA polymerase-y are similar to those reported by Fridlender et al. (1972) , Loeb (1974) and Lewis et al. (1974a) (rC) oligo(dG) is poorly utilized with either bivalent cation. Less activity was observed at pH7.5 than at pH7.8, agreeing with the pH optimum of 7.6-8.0 reported by Fridlender et al. (1972) . DNA polymerase-y also showed a preference for 0.125M-KCl rather than 0.06M-KCl.
The reverse transcriptase from myelofibrotic spleen showed a strong preference for poly(rC) .oligo(dG) and poly(rA) -(dT)12, characteristic for mammalian C-type oncornavirus DNA polymerase (Baltimore & Smoler, 1971) . Optimal activities were obtained when the KC1 concentration was 60-125mM at pH7.5. Variations in the Mn2+ cation concentration (Fig. 6) showed optimal activities between 0.8 and 1.0mm. The Mg2+ cation concentration was also tested (0-18imM) and the optimal concentration was found to be 8-12mM. Table 3 shows the results of antibody inhibition Data from other laboratories further support these observations. Reverse transcriptase isolated from human acute-myeloblastic-leukaemia cells has shown cross-reactivity only with gibbon-ape leukaemia virus and simian sarcoma virus (Todaro & Gallo, 1973) . Simian sarcoma virus was found to be the closest to, but not identical with, HL23V-1, a human leukaemia virus purified from long-term cultures of myeloid cells from a leukaemia patient (Teich et al., 1975) . 1977 Nooter et al. (1975 have described the isolation of a virus related to simian sarcoma virus from human leukaemia cells.
Serological specificities
Discussion
The results reported in the present paper are useful for two reasons. First, it is the first DNA polymerase isolated from a human malignant tissue that strictly meets the biochemical and immunological criteria defining a reverse transcriptase; the other enzyme that also meets these requirements is the reverse transcriptase from human leukaemic cells . The fact that 3 weeks after surgery this child developed acute myelogenous leukaemia makes this study even more interesting, indicating the prognostic role of this enzyme in human malignancy. Secondly, the application of antibodies to this human reverse transcriptase is the first approach to establish the serological relatedness of the human enzyme to reverse transcriptases from the primate tumour viruses or endogenous viruses. The fact that our antibodies do not inhibit the DNA polymerase activity of baboon endogenous virus indicates that the oncornaviral information in the human spleen was not derived from the endogenous virus, but was rather a consequence of some infective pathway. This is analogous to the observations by Mayer et al. (1974) , who were able to inhibit the reverse transcriptase activity from Rhesus monkey placenta by antibodies to reverse transcriptase from baboon endogenous virus, but failed to inhibit the same activity by antibodies to reverse transcriptases from primate RNA tumour viruses. Mayer et al. (1974) have implied that the reverse transcriptase activity of Rhesus monkey placenta must have been derived from an endogenous virus, i.e. class I viruses according to the nomenclature of .
Gallo et al. (R. C. Gallo, unpublished work) have isolated, from plasma membranes of blood and bonemarrow cells of patients with acute myelogenous leukaemia, natural antibodies that do not react with the reverse transcriptases from RNA tumour viruses of primate origin, but consistently react very strongly with reverse transcriptase from HL-23 virus, isolated from an acute myelogenous leukaemia patient. They have found that these antibodies had a very strong neutralizing effect on our reverse transcriptase; this was comparable with the inhibition of their HL-23 virus reverse transcriptase by these antibodies. This suggests that their reverse transcriptase from an acute myelogenous leukaemia patient, and our reverse transcriptase from a patient with a pre-leukaemic disease, are antigenically almost identical.
